Control of the koala (Phascolarctos cinereus) anterior pituitary-gonadal axis with analogues of GnRH

2008 ◽  
Vol 20 (5) ◽  
pp. 598 ◽  
Author(s):  
Camryn D. Allen ◽  
Michelle Burridge ◽  
Mandy L. Chafer ◽  
Vere N. Nicolson ◽  
Sophia C. Jago ◽  
...  
Keyword(s):  
Gnrh Agonist ◽  
Anterior Pituitary ◽  
Luteal Phase ◽  
Gnrh Antagonist ◽  
Cell Function ◽  
Phascolarctos Cinereus ◽  
Natural Sequence ◽  
Dose Rates ◽  
Anterior Pituitary Function ◽  
Gonadotrophin Releasing Hormone

The aim of the present study was to determine whether analogues of gonadotrophin-releasing hormone (GnRH) could be used to both induce an acute testosterone response and suppress anterior pituitary function in male koalas, and induce a luteal phase in female koalas. Experiment 1 characterised the steroidogenic response of male koalas to administration of 30 μg (4.3 μg kg–1) natural-sequence GnRH. Intra-muscular injection of natural-sequence GnRH induced the release of LH and testosterone with peak concentrations at 30 min (3.7 ± 1.9 ng mL–1) and 2 h (5.4 ± 0.5 ng mL–1), respectively. In Experiment 2, a single injection of the GnRH antagonist acyline (100 μg (14.3 μg kg–1) or 500 μg (71.4 μg kg–1)) did not influence the testosterone response to subsequent injections of natural-sequence GnRH. In Experiment 3, 4 μg (~0.67 μg kg–1) of the GnRH agonist buserelin induced a luteal phase in five female koalas based on a LH surge, secretion of progestogen, and a normal-length oestrous cycle. The findings have shown that (1) natural-sequence GnRH can be used to test gonadotroph cell function and determine the testosterone-secreting capacity of male koalas, (2) the GnRH antagonist, acyline, at the dose rates used, does not suppress the pituitary-testis axis in male koalas, and (3) the GnRH agonist, buserelin, induces a normal luteal phase in female koalas.

Regulation of gonadotrophin-releasing hormone receptor mRNA expression in the sheep

1994 ◽  
Vol 143 (1) ◽  
pp. 175-182 ◽  
Author(s):  
J Brooks ◽  
A S McNeilly
Keyword(s):  
Gnrh Agonist ◽  
Hormone Receptor ◽  
Luteal Phase ◽  
Gnrh Antagonist ◽  
Single Injection ◽  
Mrna Levels ◽  
Releasing Hormone ◽  
Gonadotrophin Releasing Hormone ◽  
Oestradiol Production

Abstract To investigate the regulation of the sheep gonadotrophin-releasing hormone receptor (GnRH-R) gene expression, two different treatment regimes were used. Experiment 1 examined the effects of twice daily injections of ovine follicular fluid (oFF, 15 ml s.c.) as a source of inhibin, and daily GnRH antagonist injections (Nal-Glu.HOAc, 2 mg s.c.) on days 9–12 of the oestrous cycle. Luteolysis was induced on day 12 with prostaglandin (PG) and the ewes killed at two different stages; day 12 (luteal) and 18 h after PG injection. Experiment 2 examined the effect of a single injection of oestradiol benzoate (100 μg i.m.) 18 h before death in luteal phase ewes and ewes chronically implanted with the GnRH agonist, buserelin. In both experiments, pituitaries were removed at death for determination of pituitary GnRH binding, LH content and levels of GnRH-R and LHβ mRNA. In addition in experiment 1, follicles ≥2·5 mm were dissected from the ovaries for determination of oestradiol content. In experiment 1, oFF treatment during the luteal phase completely inhibited follicle oestradiol production but was without effect on the other parameters measured. After cessation of oFF treatment and induction of luteolysis, a significant (P<0·05) increase in plasma LH occurred but the normal follicular increase in both GnRH-R mRNA levels and GnRH binding seen in control ewes was prevented. GnRH antagonist treatment alone or in combination with oFF also inhibited follicle oestradiol production, prevented the increase in GnRH-R mRNA, completely inhibited GnRH binding and significantly decreased LHβ mRNA levels. Pituitary LH content was unaffected by any treatment. In experiment 2, oestradiol treatment did not affect GnRH-R mRNA levels, GnRH binding, LHβ mRNA or pituitary LH content in luteal phase ewes, whilst chronic GnRH agonist treatment acted to decrease these parameters dramatically. A single injection of oestradiol in the GnRH agonist treated ewes significantly (P<0·05) increased GnRH-R mRNA levels and completely restored GnRH binding to luteal levels, without any effect on LHβ mRNA or pituitary LH content. These results suggest that the control of GnRH receptor expression in the sheep is directly related to oestradiol and not to the action of GnRH itself. Journal of Endocrinology (1994) 143, 175–182

Suppression of pituitary-testis function in rats treated neonatally with a gonadotrophin-releasing hormone agonist and antagonist: acute and long-term effects

1989 ◽  
Vol 123 (1) ◽  
pp. 83-91 ◽  
Author(s):  
K.-L. Kolho ◽  
I. Huhtaniemi
Keyword(s):  
Body Weight ◽  
Gnrh Agonist ◽  
Gnrh Antagonist ◽  
Long Term Effects ◽  
Adult Rats ◽  
Releasing Hormone ◽  
Serum Lh ◽  
Accessory Sex Organs ◽  
Gonadotrophin Releasing Hormone

ABSTRACT The acute and long-term effects of pituitary-testis suppression with a gonadotrophin-releasing hormone (GnRH) agonist, d-Ser(But)6des-Gly10-GnRH N-ethylamide (buserelin; 0·02, 0·1, 1·0 or 10 mg/kg body weight per day s.c.) or antagonist, N-Ac-d-Nal(2)1,d-p-Cl-Phe2,d-Trp3,d-hArg(Et2)6,d-Ala10-GnRH (RS 68439; 2 mg/kg body weight per day s.c.) were studied in male rats treated on days 1–15 of life. The animals were killed on day 16 (acute effects) or as adults (130–160 days; long-term effects). Acutely, the lowest dose of the agonist decreased pituitary FSH content and testicular LH receptors, but with increasing doses pituitary and serum LH concentrations, intratesticular testosterone content and weights of testes were also suppressed (P< 0·05–0·01). No decrease was found in serum FSH or in weights of accessory sex organs even with the highest dose of the agonist, the latter finding indicating continuing secretion of androgens. The GnRH antagonist treatment suppressed pituitary LH and FSH contents and serum LH (P< 0·05–0·01) but, as with the agonist, serum FSH remained unaltered. Testicular testosterone and testis weights were decreased (P <0·01) but testicular LH receptors remained unchanged. Moreover, the seminal vesicle and ventral prostate weights were reduced, in contrast to the effects of the agonists. Pituitary LH and FSH contents had recovered in all adult rats treated neonatally with agonist and there was no effect on serum LH and testosterone concentrations or on fertility. In contrast, in adult rats treated neonatally with antagonist, weights of testis and accessory sex organs remained decreased (P <0·01–0·05) but hormone secretion from the pituitary and testis had returned to normal except that serum FSH was increased by 80% (P <0·01). Interestingly, 90% of the antagonist-treated animals were infertile. It is concluded that treatment with a GnRH agonist during the neonatal period does not have a chronic effect on pituitary-gonadal function. In contrast, GnRH antagonist treatment neonatally permanently inhibits the development of the testis and accessory sex organs and results in infertility. Interestingly, despite the decline of pituitary FSH neonatally, neither of the GnRH analogues was able to suppress serum FSH values and this differs from the concomitant changes in LH and from the effects of similar treatments in adult rats. Journal of Endocrinology (1989) 123, 83–91

Progesterone ensures full-length luteal phases during the breeding season in ewes

1991 ◽  
Vol 129 (3) ◽  
pp. 371-379 ◽  
Author(s):  
S. J. Legan ◽  
H. I'Anson ◽  
P. Neiser
Keyword(s):  
Serum Concentration ◽  
Breeding Season ◽  
Gnrh Agonist ◽  
Luteal Phase ◽  
Full Length ◽  
Serum Concentrations ◽  
Phase Increment ◽  
End Of Treatment ◽  
Prostaglandin F ◽  
Gonadotrophin Releasing Hormone

ABSTRACT To test the hypothesis that each luteal-phase increase in the serum concentration of progesterone throughout the breeding season prevents a short luteal phase in the next cycle, 22 ewes were treated with an i.v. injection of 10 μg gonadotrophin-releasing hormone (GnRH) agonist every 12 h for 33 days beginning on day 12 of a cycle synchronized with prostaglandin F2α. Six days after the last injection of GnRH agonist, ten of the ewes were treated s.c. for 14 days with progesterone-containing silicone elastomer implants to generate luteal-phase serum concentrations. Twenty ewes stopped cycling during GnRH agonist treatment and 16 of these, eight controls and eight treated with progesterone, resumed cycling after the end of treatment. In the control ewes, oestrous cycles began 25·0±7·5 (s.e.m.) days after the end of GnRH agonist administration, a short luteal phase preceding initiation of cycles in six ewes. In contrast, all eight progesterone-treated ewes resumed cycling synchronously 22·0 ±0·2 days after the end of GnRH agonist treatment and all began with full-length luteal phases. These results support the hypothesis that each luteal-phase increment in the serum concentration of progesterone throughout the breeding season prevents a short luteal phase in the next cycle. Journal of Endocrinology (1991) 129, 371–379

A gonadotrophin-releasing hormone (GnRH) antagonist inhibits GnRH- but not LH-induced meiosis in follicle-enclosed rat oocytes in vitro

1982 ◽  
Vol 101 (2) ◽  
pp. 264-267 ◽  
Author(s):  
C. Ekholm ◽  
T. Hillensjö ◽  
W. J. Le Maire ◽  
C. Magnusson ◽  
C. S. Sheela Rani
Keyword(s):  
Gnrh Agonist ◽  
Gnrh Antagonist ◽  
Similar Response ◽  
Releasing Hormone ◽  
Lactate Accumulation ◽  
Receptor Sites ◽  
Gonadotrophin Releasing Hormone ◽  
Stimulation Of

Abstract. Previous studies have shown that gonadotrophin-releasing hormone (GnRH) can induce resumption of meiosis in follicle-enclosed rat oocytes. In the present study a GnRH antagonistic analogue ([d-pGlul, d-Phe2,-d-Trp3,6]LRF) was found to effectively abolish the stimulatory effect of a GnRH agonist upon resumption of meiosis and lactate accumulation in isolated pre-ovulatory rat follicles but the have no effect on LH stimulation of these parameters. It is concluded that although LH and GnRH can evoke a similar response they act through separate receptor sites and that it is unlikely that GnRH mediates the effect of LH on meiosis or glycolysis.

Use of the gonadotrophin-releasing hormone antagonist azaline B to control the oestrous cycle in the koala (Phascolarctos cinereus)

2016 ◽  
Vol 28 (11) ◽  
pp. 1686 ◽  
Author(s):  
K. Ballantyne ◽  
S. T. Anderson ◽  
M. Pyne ◽  
V. Nicolson ◽  
A. Mucci ◽  
...  
Keyword(s):  
Gnrh Antagonist ◽  
Day Treatment ◽  
Dependent Manner ◽  
Phascolarctos Cinereus ◽  
Subcutaneous Injections ◽  
Releasing Hormone ◽  
Gonadotrophin Releasing Hormone ◽  
June July ◽  
Dose Dependent ◽  
Cessation Of Treatment

The present study examined the effectiveness of the gonadotrophin-releasing hormone (GnRH) antagonist azaline B to suppress plasma LH and 17β-oestradiol concentrations in koalas and its potential application for oestrous synchronisation. In Experiment 1, single subcutaneous injections of azaline B successfully blocked the LH response to exogenous mammalian (m) GnRH in a dose-dependent manner; specifically, 0 mg (n = 4) did not suppress the LH response, 1 mg azaline B (n = 6) suppressed the LH response for 24 h (P < 0.05), 3.3 mg azaline B (n = 8) suppressed the LH response significantly in all animals only for 3 h (P < 0.05), although in half the animals LH remained suppressed for up to 3 days, and 10 mg azaline B (n = 4) suppressed the LH response for 7 days (P < 0.05). In Experiment 2, daily 1 mg, s.c., injections of azaline B over a 10-day period during seasonal anoestrus (June–July; n = 6) suppressed (P < 0.01) the LH response to mGnRH consecutively over the 10-day treatment period and, 4 days after cessation of treatment, the LH response had not recovered. Experiment 3 was designed to test the efficacy of daily 1 mg, s.c., azaline B over 10 days to suppress plasma LH and 17β-oestradiol concentrations and ultimately synchronise timed return to oestrus during the breeding season. Although azaline B treatment did not suppress basal LH or 17β-oestradiol, oestrus was delayed in all treated females by 24.2 days, but with high variability (range 9–39 days). Overall, the present study demonstrates that the GnRH antagonist azaline B is able to inhibit the LH response in koalas to exogenous mGnRH and successfully delay the return to oestrus. However, although azaline B clearly disrupts folliculogenesis, it has not been able to effectively synchronise return to oestrus in the koala.

Sign in / Sign up

Export Citation Format

Share Document